Clinical Trial: Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment
Study Status: Completed
Recruit Status: RECRUITING
Condition: Gynecologic Cancer
Study Type: INTERVENTIONAL
Official Title: Evaluation of a Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment in an Underserved Gynecology Population
Brief Summary:
In this study, the investigators aim to compare a mobile health platform, known as a 'chatbot,' that leverages artificial intelligence and natural language processing to scale communication, to 'usual care' that patients would receive.This comparison will enable the investigators to determine if the chatbot system can improve rates of recommendation for genetic testing among patients at elevated risk of harboring a familial cancer syndrome in an all-Medicaid gynecology clinic.Furthermore, the…
Read more